Page last updated: 2024-12-08
cysteinolic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
cysteinolic acid: RN given from Toxlit 5/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 167538 |
SCHEMBL ID | 3875790 |
MeSH ID | M0156023 |
Synonyms (8)
Synonym |
---|
cysteinolic acid |
(2s)-2-amino-3-hydroxypropane-1-sulfonic acid |
16421-58-2 |
2-amino-3-hydroxy-1-propane sulfonic acid |
1-propanesulfonic acid, 2-amino-3-hydroxy-, (s)- |
SCHEMBL3875790 |
2-amino-3-hydroxypropane-1-sulfonic acid |
DTXSID10936922 |
Research Excerpts
Overview
D-Cysteinolic acid is a zwitterionic aminosulfonate found in marine (and occasionally freshwater) environments.
Excerpt | Reference | Relevance |
---|---|---|
"D-Cysteinolic acid is a zwitterionic aminosulfonate found in marine (and occasionally freshwater) environments. " | ( Chemistry and biology of the aminosulfonate cysteinolic acid: discovery, distribution, synthesis and metabolism. Burchill, L; Williams, SJ, 2022) | 1.7 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |